Skip to main content

RVTY

Stock
Health Care
Diagnostics & Research

Performance overview

RVTY Price
Price Chart

Forward-looking statistics

Beta
0.72
Risk
30.10%

Detailed forecast

[disclaimer]

Individual forecast components (weighted-sum)

Company Profile

Revvity provides instruments, tests, services, and software solutions to the pharmaceutical, biomedical, chemical, environmental, and general industrial markets. The company operates in two segments. First, its diagnostics segment includes immunodiagnostics, reproductive health, and applied genomics. Second, its discovery and analytical solutions is composed of life science, industrial, environmental, and food applications. Revvity offers products and services ranging from genetic screening and environmental analytical tools to informatics and enterprise software.

Company info

SectorHealth Care
IndustryDiagnostics & Research
Employees10K
Market cap$13.7B

Fundamentals

Enterprise value$13.6B
Revenue$2.8B
Revenue per employee
Profit margin10.35%
Debt to equity43.54

Security info

ExchangeNyse American
Type of shareCommon Stock
Earnings per share (EPS)$2.42
Dividend per share$0.28
Revenue per share$22.72
Avg trading volume (30 day)$106M
Avg trading volume (10 day)$105M
Put-call ratio

Macro factor sensitivity

Growth-0.1
Credit+4.0
Liquidity+0.1
Inflation-2.8
Commodities+0.0
Interest Rates-1.9

Valuation

Dividend yield0.28%
PEG Ratio19.63
Price to sales4.31
P/E Ratio19.63
Enterprise Value to Revenue4.91
Price to book1.58

Upcoming events

Next earnings dayApril 28, 2025
Next dividend day
Ex. dividend dayJuly 18, 2025

News

Revvity (RVTY) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release

Revvity (RVTY) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Investment Research (July 21, 2025)
RVTY Stock Falls Despite the Latest Launch of Automated Instrument

Revvity unveils IDS i20, a fully automated immunodiagnostics platform designed to enhance lab efficiency and expand specialty testing.

Zacks Investment Research (May 23, 2025)
Life Science Tools Maker Revvity Delivers Strong Q1 Earnings Despite Evolving Macroeconomic Backdrop

Revvity Inc. RVTY stock is trading higher on Monday after the company reported better-than-expected first-quarter 2025 earnings.

Benzinga (April 28, 2025)

Unlock Personalized Financial Tools

All our core financial tools are completely free. Create an account to save your research, get personalized recommendations, and enjoy unlimited access.

Save research to draft portfolios
Get personalized recommendations
Access unlimited tool usage
Sign up for free